https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2026-0051
Announcing a new publication for
Acta Materia Medica journal. Poor oral bioavailability is often viewed as a barrier to the development of medicines from traditional and indigenous pharmacopeias. Berberine, a major alkaloid of Coptidis Rhizoma, challenges this assumption because it shows glucose-lowering activity despite limited systemic exposure. This commentary examines whether intestinally restricted mitochondrial and metabolic actions may represent a development opportunity. Recent intestine-specific NDI1 experiments demonstrated that inhibition of mitochondrial complex I in the intestinal epithelium contributes to the acute glucose-lowering effects of oral metformin and berberine in mice. These findings align with earlier observations that metformin enhances intestinal glucose uptake, glycolysis, lactate production, and gut-derived metabolic signaling, and provide a mechanistic framework for the local actions, microbial conversion, and poor absorption of berberine. For selected ethnomedicine-derived compounds, therapeutic development might optimize exposure at the site required for efficacy rather than maximize plasma bioavailability. Nevertheless, intestinal complex I is a predominantly preclinical antidiabetic target, and citrulline remains a candidate pharmacodynamic biomarker rather than a validated measure of target engagement. Quantitative comparisons must retain the species, dose, sampling compartment, and assay context; lower systemic exposure is not, by itself, evidence of superior efficacy or safety.
# # # # # #
Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.
Submission Process
Submissions
to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at
https://mc04.manuscriptcentral.com/ammed
Queries about the journal can be sent to
editorialoffice@amm-journal.org.
Please visit
https://amm-journal.org/ to learn more about the journal.
Editorial Board: https://amm-journal.org/index.php/editorial-board/
There are no author submission or article processing fees.
Follow
Acta Materia Medica on Twitter
https://twitter.com/AMM_journal;
Facebook (
https://www.facebook.com/AMMjournal)
eISSN 2737-7946
# # # # # #
Liang Le and Baoping Jiang. Rethinking oral bioavailability in drug discovery: lessons from metformin, berberine, and intestinal mitochondrial complex I.
Acta Materia Medica. 2026. Vol. 5(2):221-228. DOI: 10.15212/AMM-2026-0051